We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
-12.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12.1B
AUM Growth
-$2.55B
(-17%)
Cap. Flow
-$469M
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
25.18%
Holding
858
New
52
Increased
315
Reduced
272
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$38.7M |
| 2 |
Apple
AAPL
|
+$27.7M |
| 3 |
Salesforce
CRM
|
+$26.1M |
| 4 |
Verizon
VZ
|
+$25.9M |
| 5 |
PepsiCo
PEP
|
+$24.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.7M |
| 2 |
Waste Management
WM
|
+$64.8M |
| 3 |
Sociedad Química y Minera de Chile
SQM
|
+$58.6M |
| 4 |
Citigroup
C
|
+$56.5M |
| 5 |
Johnson & Johnson
JNJ
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.24% |
| 2 | Technology | 24.24% |
| 3 | Financials | 8.36% |
| 4 | Communication Services | 6.82% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Exelixis
EXEL
$13.9B
| $39.7M | 0.33% |
1,905,544
+323,228
| +20% | +$6.66M |
|
|
ANSS
77
DELISTED
Ansys
ANSS
| $39.5M | 0.33% |
165,046
+12,014
| +8% | +$3.18M |
|
78
Darling Ingredients
DAR
$9.93B
| $38.1M | 0.31% |
637,881
-25,807
| -4% | -$1.96M |
|
79
NextEra Energy
NEE
$187B
| $37.5M | 0.31% |
483,633
+164,172
| +51% | +$12.5M |
|
80
Otis Worldwide
OTIS
$27.4B
| $37.2M | 0.31% |
525,979
+94,877
| +22% | +$6.99M |
|
81
Insmed
INSM
$23.2B
| $37.1M | 0.31% |
1,882,448
+423,974
| +29% | +$8.88M |
|
82
Booking.com
BKNG
$138B
| $37M | 0.3% |
529,250
-420,350
| -44% | -$35.9M |
|
|
TPTX
83
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $36.9M | 0.3% |
490,585
-12,703
| -3% | -$565K |
|
84
S&P Global
SPGI
$126B
| $36.3M | 0.3% |
107,569
-25,442
| -19% | -$9.07M |
|
85
BioNTech
BNTX
$22.6B
| $35.5M | 0.29% |
238,134
-4,000
| -2% | -$611K |
|
86
Bio-Rad Laboratories Class A
BIO
$8.42B
| $34.8M | 0.29% |
70,283
-407
| -0.6% | -$212K |
|
87
Stryker
SYK
$127B
| $34.7M | 0.29% |
174,428
-14,141
| -7% | -$3.32M |
|
88
Broadcom
AVGO
$1.82T
| $34M | 0.28% |
699,590
+100,910
| +17% | +$5.66M |
|
89
MasTec
MTZ
$26.7B
| $34M | 0.28% |
474,078
+63,533
| +15% | +$4.95M |
|
90
Lowe's Companies
LOW
$116B
| $33.9M | 0.28% |
194,192
-13,291
| -6% | -$2.56M |
|
91
Intuit
INTU
$81.1B
| $33.5M | 0.28% |
86,841
-15,360
| -15% | -$6.36M |
|
92
BioMarin Pharmaceuticals
BMRN
$11.5B
| $32.5M | 0.27% |
391,630
-21,647
| -5% | -$1.72M |
|
93
Neurocrine Biosciences
NBIX
$17.7B
| $32.3M | 0.27% |
330,929
+30,722
| +10% | +$2.84M |
|
94
Intuitive Surgical
ISRG
$121B
| $32M | 0.26% |
159,437
+4,019
| +3% | +$943K |
|
95
PNC Financial Services
PNC
$100B
| $31.9M | 0.26% |
202,313
-1,285
| -0.6% | -$215K |
|
96
Silicon Laboratories
SLAB
$7.15B
| $31.3M | 0.26% |
223,377
+4,077
| +2% | +$571K |
|
|
SCHW
97
Charles Schwab
SCHW
$177B
| $30.4M | 0.25% |
481,074
-55,544
| -10% | -$3.83M |
|
98
American Express
AXP
$223B
| $30.2M | 0.25% |
217,976
-3,925
| -2% | -$648K |
|
|
BLD
99
DELISTED
TopBuild
BLD
| $30.2M | 0.25% |
180,614
+20,400
| +13% | +$3.73M |
|
100
ExxonMobil
XOM
$651B
| $29.7M | 0.24% |
347,019
-2,202
| -0.6% | -$199K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2022 Portfolio in Review
As of Q2 2022, Candriam SCA held 858 positions worth $12.1B, down 17% from $14.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Candriam SCA withdrew a net $469M in Q2 2022, closing 83 positions and reducing 272 holdings. Its most notable exit was TriState Capital Holdings, Inc., an estimated $20.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Technology and Financials.
Against the trend, Candriam SCA opened a new position in Tenable Holdings worth $16.3M.
- Candriam SCA's largest Q2 2022 buy was Tenable Holdings: 359,981 shares worth $16.3M.
- Candriam SCA added most to Procter & Gamble in Q2 2022, an estimated $38.7M increase.
- Candriam SCA's biggest Q2 2022 reduction was Microsoft, cutting an estimated $65.7M.
- Candriam SCA fully exited TriState Capital Holdings, Inc. in Q2 2022, selling an estimated $20.9M.
- Candriam SCA's ten largest holdings make up 25% of its $12.1B portfolio in Q2 2022.
- Candriam SCA opened 52 new positions and closed 83 in Q2 2022.
- Candriam SCA's portfolio value fell 17% quarter-over-quarter to $12.1B.
Based on Candriam SCA's 13F filing for Q2 2022, filed 3 Aug 2022.